A morphometric study of the hepatic arterioles in end-stage primary sclerosing cholangitis

M Isabel Fiel1, Hamid R Sima, Amirabbas Azarian

  • 1Department of Pathology, The Mount Sinai Medical Center, Box 1194, New York, NY, USA, mariaisabel.fiel@mountsinai.org.

Insights

Primary sclerosing cholangitis (PSC) involves enlarged hepatic arterioles with increased wall thickness, distinct from cirrhosis. These vascular changes may play a role in PSC development.

Area of Science:

  • Hepatology
  • Vascular Biology
  • Pathology

Background:

  • Primary sclerosing cholangitis (PSC) is characterized by periductal fibroinflammatory lesions.
  • Hepatic arteriole morphology in PSC is not well understood.

Purpose of the Study:

  • To investigate and characterize the dimensions of hepatic arterioles in patients with PSC.
  • To compare arteriole dimensions in PSC with those in other cirrhotic liver diseases.

Main Methods:

  • Image analysis of hematoxylin and eosin-stained liver explants from 30 PSC patients and 10 controls (primary biliary cirrhosis, hepatitis C, alcoholic liver disease).
  • Measurement of hepatic arteriole length, width, wall thickness, and luminal area using standardized image analysis techniques.

Main Results:

  • Hepatic arterioles in PSC showed significantly greater mean length, width, and wall thickness compared to controls.
  • Increased arteriole wall thickness in PSC was observed even when compared to individual cirrhotic subgroups.
  • Luminal area of hepatic arterioles was similar across all groups studied.

Conclusions:

  • End-stage PSC exhibits larger hepatic arterioles with greater wall thickness than other cirrhotic livers.
  • The observed arteriolar changes in PSC are not solely attributable to the presence of cirrhosis.
  • These distinct vascular alterations may contribute to the pathogenesis of primary sclerosing cholangitis.